BioNTech SE Investor

BioNTech SE is a company that specializes in developing immunotherapies for cancer and other diseases. They use cutting-edge technologies to create personalized treatments for patients based on their individual genetic profiles. The company has partnerships with several pharmaceutical companies and is currently working on developing a COVID-19 vaccine in collaboration with Pfizer.


Invests into

Headquarters: Mainz, Rheinland-Pfalz, Germany
Investor Type: Venture Funds